文献速递泌尿生殖技术与安全US

靶向前列腺六次跨膜上皮抗原1的超声造影微泡改善前列腺癌在体检测

Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.
PubMed 文献 · J Ultrasound Med · 2018-07-19

本研究在裸鼠前列腺癌移植瘤模型中,将生物素化STEAP-1单克隆抗体偶联至链霉亲和素包被的SonoVue微泡,分别用普通SonoVue微泡与STEAP-1靶向SonoVue微泡行超声造影检测前列腺肿瘤,测量峰值强度、达峰时间、曲线下面积和平均通过时间;结果显示靶向微泡生物学特性稳定、可体外成功结合前列腺癌细胞系,注射后超声信号强度增强优于普通微泡,且移植瘤超声信号强度较高与STEAP-1表达水平升高相关;作者认为该靶向微泡可改善前列腺癌超声可视化并更有效识别肿瘤,需前瞻性研究在患者中验证。

要点

  • STEAP-1靶向SonoVue微泡生物学特性稳定,可体外成功结合前列腺癌细胞系。
  • 注射STEAP-1靶向微泡后超声信号强度增强优于普通SonoVue微泡。
  • 前列腺癌移植瘤超声信号强度较高与STEAP-1表达水平升高相关。

核心结论

  • 作者认为携带STEAP-1单克隆抗体的SonoVue微泡可改善前列腺癌的超声可视化并在在体更有效识别肿瘤。

研究设计与样本

  • 裸鼠前列腺癌移植瘤模型在体研究,对比普通SonoVue微泡与STEAP-1靶向SonoVue微泡行超声造影检测前列腺肿瘤,测量峰值强度、达峰时间、曲线下面积和平均通过时间。

关键影像表现/征象

  • 注射STEAP-1靶向SonoVue微泡后超声信号强度增强,优于普通SonoVue微泡。
  • 前列腺癌移植瘤超声信号强度较高与STEAP-1表达水平升高相关。

局限性

  • 作者指出需前瞻性研究在患者中验证该发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the feasibility of the 6-transmembrane epithelial antigen of the prostate-1 (STEAP-1)-targeted microbubbles for enhancing ultrasound imaging of prostate tumors in the nude mouse xenograft models.

METHODS: Contrast agents were established by conjugating biotinylated STEAP-1 monoclonal antibodies with streptavidin coated SonoVue microbubbles. Then, ordinary SonoVue (Bracco, Milan, Italy) microbubble and STEAP-1-targeted SonoVue microbubble were used, respectively, for contrast-enhanced sonography to detect prostate tumors in the nude mouse xenograft models. The characteristics, including peak intensity, time to peak, area under the curve, and mean transit time, were measured.

RESULTS: The biological characteristics of STEAP-1-targeted SonoVue microbubbles were stable. STEAP-1-targeted SonoVue microbubbles can successfully conjugate to prostate cancer cell lines in vitro. Enhancement of ultrasound signal intensity was determined after injection of STEAP-1-targeted SonoVue microbubble, compared with ordinary SonoVue microbubble. Higher intensities of ultrasound signals in xenograft tumor of prostate cancer were associated with increased levels of STEAP-1 expression.

CONCLUSION: Our results suggest that SonoVue microbubble carrying STEAP-1 monoclonal antibody could improve the ultrasound visualization of prostate cancer and identify the tumor more effectively in vivo. A prospective study is required to validate our finding in patients with prostate cancer.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Yuan Y, Liu Y, Zhu XM, et al. Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo. J Ultrasound Med. 2018. PMID: 30027616. doi:10.1002/jum.14689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。